| Drug Type Small molecule drug | 
| Synonyms 3-caffeoylquinic-acid, 3-O-caffeoylquinic-acid, Coffee tannic acid + [1] | 
| Target | 
| Action stimulants, inhibitors | 
| Mechanism Akt stimulants(Proto-oncogene proteins c-akt stimulants), DNMT1 inhibitors(DNA (cytosine-5)-methyltransferase 1 inhibitors), LAG3 inhibitors(Lymphocyte activation gene 3 protein inhibitors) | 
| Therapeutic Areas | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC16H18O9 | 
| InChIKeyCWVRJTMFETXNAD-NCZKRNLISA-N | 
| CAS Registry327-97-9 | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | Chlorogenic acid | - | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Glioblastoma Multiforme | Phase 3 | China  | 27 Nov 2018 | |
| Lung Cancer | Phase 2 | China  | 17 Jul 2018 | |
| Non-squamous non-small cell lung cancer | Phase 2 | China  | 17 Jul 2018 | |
| Recurrent Lung Small Cell Carcinoma | Phase 2 | China  | 17 Jul 2018 | |
| Advanced Lung Adenocarcinoma | Phase 1 | China  | 12 Sep 2018 | |
| Advanced Lung Small Cell Carcinoma | Phase 1 | China  | 12 Sep 2018 | |
| Advanced Lung Squamous Cell Carcinoma | Phase 1 | China  | 12 Sep 2018 | |
| Kidney Neoplasms | Phase 1 | China  | 24 Oct 2014 | |
| Liver Cancer | Phase 1 | China  | 24 Oct 2014 | |
| Locally Advanced Malignant Neoplasm | Phase 1 | China  | 01 Sep 2014 | 
| Phase 2 | 30 | Placebo (Placebo) | rkxpblyxzl(fcycpmlihv) = tfleuzjqhq ninefrysov  (nemwwqfwqw, 0.3) View more | - | 02 Aug 2019 | ||
| (Chlorogenic Acid) | rkxpblyxzl(fcycpmlihv) = uiisyujudd ninefrysov  (nemwwqfwqw, 0.4) View more | 





